Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage

Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage

The habitual intake of large amounts of sugar, which has been implicated in the onset/progression of lifestyle-related diseases (LSRD), induces the excessive production of glyceraldehyde (GA), an intermediate of sugar metabolism, in neuronal cells, hepatocytes, and cardiomyocytes. Reactions between...

Full description

Bibliographic Details
Main Authors:	Masayoshi Takeuchi, Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama, Chigusa Kikuchi, Ayako Furukawa, Kentaro Nagamine, Takamitsu Hori, Tamihide Matsunaga
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Biomolecules
Subjects:	advanced glycation end-products (AGEs) toxic AGEs (TAGE) Alzheimer’s disease (AD) non-alcoholic steatohepatitis (NASH) cardiovascular disease (CVD) lifestyle-related diseases (LSRD)
Online Access:	https://www.mdpi.com/2218-273X/11/3/387

Similar Items

Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases
by: Masayoshi Takeuchi
Published: (2016-06-01)

The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review
by: Akiko Sakasai-Sakai, et al.
Published: (2019-02-01)

Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver
by: Takanobu Takata, et al.
Published: (2019-07-01)

Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells
by: Akiko Sakasai-Sakai, et al.
Published: (2020-07-01)

Potential of an Interorgan Network Mediated by Toxic Advanced Glycation End-Products in a Rat Model
by: Shinya Inoue, et al.
Published: (2021-12-01)

Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD
by: Masayoshi Takeuchi, et al.
Published: (2017-06-01)

Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle
by: Masayoshi Takeuchi
Published: (2020-11-01)

The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases
by: Natalia Arias, et al.
Published: (2020-08-01)

The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells
by: Ryuto Nasu, et al.
Published: (2020-09-01)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
by: Takanobu Takata, et al.
Published: (2020-06-01)

Bericht über den Workshop „Offener Zugang zu Daten – eine Herausforderung“ im Rahmen der Open-Access-Tage 2008 am 10.10.2008 in Berlin
by: Heinz Pampel
Published: (2009-03-01)

Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis
by: Javier Ampuero, et al.

Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review
by: Tessa Kennedy-Martin, et al.
Published: (2018-06-01)

10. Open Access-Tage (München, 10.–11. Oktober 2016)
by: Bruno Bauer, et al.
Published: (2016-12-01)

Alcohol or Not: A Review Comparing Initial Mechanisms, Contributing Factors, and Liver Transplantation Outcomes Between Alcoholic and Nonalcoholic Steatohepatitis
by: Chung-Shiung Wen, et al.
Published: (2018-09-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

Steatosis and Steatohepatitis: Complex Disorders
by: Kira Bettermann, et al.
Published: (2014-06-01)

Comparative Transcriptomics Analyses in Livers of Mice, Humans, and Humanized Mice Define Human-Specific Gene Networks
by: Chengfei Jiang, et al.
Published: (2020-11-01)

Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD)
by: Naveen Kalra, et al.
Published: (2009-01-01)

Celiac Disease, Gluten-Free Diet, and Metabolic and Liver Disorders
by: Marco Valvano, et al.
Published: (2020-03-01)

Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis
by: Ćulafić Milica, et al.
Published: (2020-01-01)

Pathohistological characteristics of steatohepatitis on needle biopsy sample from 100 patients
by: Milićević Anđela, et al.
Published: (2019-01-01)

Changes in histological criteria lead to different prevalences of nonalcoholic steatohepatitis in severe obesity
by: Cacilda Pedrosa de Oliveira, et al.
Published: (2007-10-01)

NAFLD in the Elderly
by: Alqahtani SA, et al.
Published: (2021-09-01)

Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH
by: Martina Colognesi, et al.
Published: (2020-07-01)

Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice
by: Daniel Cabrera, et al.
Published: (2021-09-01)

A simple method for inducing nonalcoholic steatohepatitis with fibrosis
by: Leyla Yahaghi, et al.
Published: (2019-12-01)

Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD)
by: Xin Xin, et al.
Published: (2019-09-01)

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
by: Alessandro Mantovani, et al.
Published: (2021-12-01)

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
by: Stephen Caldwell
Published: (2017-06-01)

Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD
by: Victoria Svop Jensen, et al.
Published: (2021-02-01)

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
by: Pratima Dibba, et al.
Published: (2018-05-01)

NAFLD: Challenges and opportunities to address the public health problem in Latin America
by: Juan Pablo Arab, et al.
Published: (2021-09-01)

Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study
by: Reda Albadawy, et al.
Published: (2021-09-01)

Identification of Accessible Hepatic Gene Signatures for Interindividual Variations in Nutrigenomic Response to Dietary Supplementation of Omega-3 Fatty Acids
by: Yu Shi, et al.
Published: (2021-02-01)

Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD – Reconciling the present with the pastKey points
by: Oyekoya T. Ayonrinde
Published: (2021-06-01)

EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2
by: V. V. Tsukanov, et al.
Published: (2016-09-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY)
by: D. Kh. Kalimullina, et al.
Published: (2017-03-01)

Involvement of the Autophagy-ER Stress Axis in High Fat/Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease
by: Xiu Zhou, et al.
Published: (2020-08-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)